docetaxel anhydrous has been researched along with trichostatin a in 5 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (trichostatin a) | Trials (trichostatin a) | Recent Studies (post-2010) (trichostatin a) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 3,365 | 7 | 1,382 |
| Protein | Taxonomy | docetaxel anhydrous (IC50) | trichostatin a (IC50) |
|---|---|---|---|
| Chain A, HDLP (HISTONE DEACETYLASE-LIKE PROTEIN) | Aquifex aeolicus | 0.4 | |
| Chain B, HDLP (HISTONE DEACETYLASE-LIKE PROTEIN) | Aquifex aeolicus | 0.4 | |
| Chain A, Histone deacetylase 7a | Homo sapiens (human) | 0.3 | |
| Chain A, Histone deacetylase 7a | Homo sapiens (human) | 0.3 | |
| Histone deacetylase 8 | Schistosoma mansoni | 3.62 | |
| Histone deacetylase | Rattus norvegicus (Norway rat) | 0.1854 | |
| Histone deacetylase 1 | Mus musculus (house mouse) | 0.0047 | |
| Histone deacetylase 3 | Homo sapiens (human) | 0.3388 | |
| 5-hydroxytryptamine receptor 3A | Cavia porcellus (domestic guinea pig) | 7.69 | |
| Histone deacetylase 3 | Mus musculus (house mouse) | 0.0014 | |
| Plasma kallikrein | Homo sapiens (human) | 0.034 | |
| Integrin beta-3 | Homo sapiens (human) | 0.0263 | |
| Cytochrome P450 1A2 | Homo sapiens (human) | 0.02 | |
| Integrin alpha-IIb | Homo sapiens (human) | 0.0263 | |
| Coagulation factor VII | Homo sapiens (human) | 0.034 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 0.005 | |
| Vitamin D3 receptor | Homo sapiens (human) | 0.087 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 0.028 | |
| Tissue factor | Homo sapiens (human) | 0.032 | |
| Adenosine receptor A1 | Bos taurus (cattle) | 0.19 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 0.005 | |
| Delta-type opioid receptor | Homo sapiens (human) | 0.1 | |
| Histamine H2 receptor | Cavia porcellus (domestic guinea pig) | 0.1 | |
| Histone deacetylase 4 | Homo sapiens (human) | 0.8532 | |
| Histone deacetylase 2 | Mus musculus (house mouse) | 0.0014 | |
| Histone deacetylase 1 | Homo sapiens (human) | 0.2343 | |
| Splicing factor 3B subunit 3 | Homo sapiens (human) | 0.5944 | |
| Histone deacetylase 1 | Rattus norvegicus (Norway rat) | 0.1854 | |
| Adenosine receptor A1 | Sus scrofa (pig) | 0.2 | |
| Histone deacetylase | Rattus norvegicus (Norway rat) | 0.1854 | |
| Histone deacetylase 4 | Mus musculus (house mouse) | 0.0014 | |
| Polyamine deacetylase HDAC10 | Mus musculus (house mouse) | 0.0014 | |
| Histone deacetylase 3 | Rattus norvegicus (Norway rat) | 0.1854 | |
| Histone deacetylase-like amidohydrolase | Alcaligenaceae bacterium FB188 | 1.2 | |
| Histone deacetylase 7 | Mus musculus (house mouse) | 0.0014 | |
| Histone deacetylase 8 | Mus musculus (house mouse) | 0.0207 | |
| Histone deacetylase 7 | Homo sapiens (human) | 0.5052 | |
| Histone deacetylase 11 | Mus musculus (house mouse) | 0.0014 | |
| Histone deacetylase 2 | Homo sapiens (human) | 0.3475 | |
| HD2 type histone deacetylase HDA106 | Zea mays | 0.006 | |
| Polyamine deacetylase HDAC10 | Homo sapiens (human) | 0.3266 | |
| Histone deacetylase 11 | Homo sapiens (human) | 0.5027 | |
| Histone deacetylase 9 | Mus musculus (house mouse) | 0.0014 | |
| Histone deacetylase 7 | Rattus norvegicus (Norway rat) | 0.1854 | |
| Histone deacetylase 6 | Rattus norvegicus (Norway rat) | 0.1854 | |
| Histone deacetylase 4 | Rattus norvegicus (Norway rat) | 0.1854 | |
| Histone deacetylase 8 | Homo sapiens (human) | 0.4994 | |
| Histone deacetylase 6 | Homo sapiens (human) | 0.2559 | |
| Histone deacetylase 9 | Homo sapiens (human) | 0.5627 | |
| Histone deacetylase 5 | Homo sapiens (human) | 0.5332 | |
| Histone deacetylase | Plasmodium falciparum (malaria parasite P. falciparum) | 0.0006 | |
| Nuclear receptor corepressor 2 | Homo sapiens (human) | 0.0138 | |
| Histone deacetylase 6 | Mus musculus (house mouse) | 0.0387 | |
| Histone deacetylase 5 | Mus musculus (house mouse) | 0.0107 | |
| Histone deacetylase | Zea mays | 0.0004 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, SJ; Ma, XB; Zhang, QC; Zhang, S | 1 |
| Bahl, A; Biernacka, KM; Gillatt, D; Holly, JM; Perks, CM; Persad, RA; Uzoh, CC; Zeng, L | 1 |
| Arnold, RD; Cummings, BS; Glenn, TC; Kolli, RT; Moore, M; Scholpa, NE | 1 |
| Hu, X; Liu, X; Nesa, EU; Niu, H; Tian, K; Xu, Q; Yuan, H; Zhang, X; Zhu, D; Zhu, S | 1 |
| Ahmed, A; Dai, J; Escara-Wilke, J; Keller, ET; Keller, J; Mizokami, A; Schnepp, PM; Shelley, G | 1 |
5 other study(ies) available for docetaxel anhydrous and trichostatin a
| Article | Year |
|---|---|
Histone deacetylase inhibitor trichostatin A enhances anti-tumor effects of docetaxel or erlotinib in A549 cell line.
Topics: Acetylation; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Caspase 3; Cell Division; Cell Line, Tumor; Cell Proliferation; Cell Survival; Docetaxel; Drug Synergism; ErbB Receptors; Erlotinib Hydrochloride; G2 Phase; Histone Deacetylase Inhibitors; HSP90 Heat-Shock Proteins; Humans; Hydroxamic Acids; Lung Neoplasms; Quinazolines; Taxoids; Tubulin | 2012 |
Hyperglycaemia-induced chemoresistance of prostate cancer cells due to IGFBP2.
Topics: Acetylation; Antineoplastic Agents; Benzamides; Cell Line, Tumor; Docetaxel; Drug Resistance, Neoplasm; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Hyperglycemia; Insulin-Like Growth Factor Binding Protein 2; Male; Naphthols; Promoter Regions, Genetic; Prostatic Neoplasms; RNA, Small Interfering; Sirtuin 1; Sirtuin 2; Taxoids | 2013 |
Nephrotoxicity of epigenetic inhibitors used for the treatment of cancer.
Topics: Acetylation; Animals; Antineoplastic Agents; Azacitidine; Cell Death; Cell Line, Tumor; Cell Proliferation; Cisplatin; Cyclin-Dependent Kinase Inhibitor p21; Docetaxel; Epigenesis, Genetic; HEK293 Cells; Histones; Humans; Hydroxamic Acids; Kidney; Male; Methylation; Neoplasms; Oligopeptides; Prostatic Neoplasms; Rats; Taxoids | 2016 |
Hyper-acetylation contributes to the sensitivity of chemo-resistant prostate cancer cells to histone deacetylase inhibitor Trichostatin A.
Topics: Acetyl Coenzyme A; Adaptor Proteins, Signal Transducing; Allografts; Animals; Antineoplastic Agents; Apoptosis; Carrier Proteins; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cisplatin; Docetaxel; Doxorubicin; Drug Resistance, Neoplasm; Endoplasmic Reticulum Stress; Eukaryotic Initiation Factors; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Male; Mice; Mice, Inbred C57BL; Phosphoproteins; Prostatic Neoplasms; Protein Isoforms; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases; Tumor Burden | 2018 |
Transcription factor network analysis based on single cell RNA-seq identifies that Trichostatin-a reverses docetaxel resistance in prostate Cancer.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Docetaxel; Drug Resistance, Neoplasm; Humans; Hydroxamic Acids; Male; Mice; Prostatic Neoplasms; Protein Interaction Maps; RNA-Seq; Single-Cell Analysis; Transcription Factors | 2021 |